前收市價 | 0.2500 |
開市 | 0.2300 |
買盤 | 0.0500 |
賣出價 | 0.3000 |
拍板 | 3.00 |
到期日 | 2024-10-18 |
今日波幅 | 0.2300 - 0.2500 |
合同範圍 | 無 |
成交量 | |
未平倉合約 | 391 |
Initial data from an early-stage study shows that treatment with Avidity's (RNA) experimental therapy could address the underlying cause of a rare muscle-weakening condition.
Data from a late-stage study shows that treatment with Amgen's (AMGN) Uplizna achieves a statistically significant reduction in the risk of flares in patients with IgG4-RD, a rare disease.
Data from a late-stage study shows that treatment with J&J's (JNJ) experimental drug met all study endpoints in depression patients with insomnia symptoms.